Voisard Asset Management Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-1,507
Closed -$78K – 143
2024
Q3
$78K Buy
1,507
+39
+3% +$1.83K 0.03% 149
2024
Q2
$61K Buy
1,468
+20
+1% +$895 0.03% 148
2024
Q1
$78.5K Buy
1,448
+17
+1% +$866 0.04% 107
2023
Q4
$73.4K Buy
+1,431
New +$75.1K 0.04% 112

Other funds holding BMY

Voisard Asset Management Group's BMY Position: Q4 2024 in Review

Voisard Asset Management Group sold out of Bristol-Myers Squibb (BMY) in Q4 2024, closing a stake of 1,507 shares — an estimated $78K sold.

Voisard Asset Management Group first reported a position in BMY in Q4 2023 and held it in 4 quarters. The position peaked at $78.5K in Q1 2024. 2,494 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

  • Voisard Asset Management Group reported no remaining Bristol-Myers Squibb position as of Q4 2024 after selling out during the quarter.
  • Voisard Asset Management Group sold 1,507 Bristol-Myers Squibb shares in Q4 2024, an estimated $78K.
  • Voisard Asset Management Group first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 4 quarters.
  • Voisard Asset Management Group's Bristol-Myers Squibb position peaked at $78.5K in Q1 2024.
  • 2,494 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Voisard Asset Management Group's 13F filing for Q4 2024, filed 7 Feb 2025.